Back to search

Article

Combination of Haloperidol with UNC9994, β-arrestin-biased analog of Aripiprazole, ameliorates schizophrenia-related phenotypes induced by NMDAR deficit in mice

2024-04-28

Abstract excerpt

<h4>Background</h4> Glutamatergic system dysfunction, particularly involving the N-methyl-D-aspartate receptor (NMDAR), contributes to a full spectrum of schizophrenia-like symptoms, including the cognitive and negative symptoms that are resistant to treatment with antipsychotic drugs (APDs). Aripiprazole, an atypical antipsychotic drug (APD), acts as a dopamine partial agonist and its combination with haloperido...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6ed1c8f1-de39-5e61-80e3-93879f2979f6
DOI
10.1101/2024.04.25.591166
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Combination of Haloperidol with UNC9994, β-arrestin-biased analog of Aripiprazole, ameliorates schizophrenia-related phenotypes induced by NMDAR deficit in miceDOI 10.1101/2024.04.25.591166
Select a neighboring publication to make it the new centre.